BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15758585)

  • 41. Chronic obstructive pulmonary disease.
    Foley NM
    SAAD Dig; 2000 Jul; 17(3):3-12. PubMed ID: 11404867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [COPD treatment by drugs].
    Nafti S
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S58-10S60. PubMed ID: 17127967
    [No Abstract]   [Full Text] [Related]  

  • 43. [Acute exacerbations of chronic obstructive pulmonary disease].
    Chabot F; Gomez E; Guillaumot A; Kheir A; Chaouat A
    Presse Med; 2009 Mar; 38(3):485-95. PubMed ID: 19185446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How have we been managing chronic obstructive pulmonary disease in Australia?
    Matheson MC; Abeysena C; Raven JM; Skoric B; Johns DP; Abramson MJ; Walters EH
    Intern Med J; 2006 Feb; 36(2):92-9. PubMed ID: 16472263
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Education of COPD patient--between pessimism and reserved optimism].
    Mihălţan F; Dragomir A; Ulmeanu R
    Pneumologia; 2006; 55(2):69-73. PubMed ID: 17069205
    [No Abstract]   [Full Text] [Related]  

  • 46. COPD: your role in early detection.
    Bruce ML; McEvoy P
    Nurse Pract; 2007 Nov; 32(11):24-33; quiz 33-4. PubMed ID: 18075455
    [No Abstract]   [Full Text] [Related]  

  • 47. Improving outcomes for COPD patients.
    Bauldoff GS; Diaz PT
    Nurse Pract; 2006 Aug; 31(8):26-8, 33-43; quiz 43-5. PubMed ID: 16966974
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of COPD exacerbations. Pharmacologic options and modification of risk factors.
    Blanchard AR
    Postgrad Med; 2002 Jun; 111(6):65-8, 71-2, 75. PubMed ID: 12082921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Stage appropriate therapy for COPD].
    Hamm H
    Internist (Berl); 2006 Sep; 47(9):901-2, 904-7. PubMed ID: 16900364
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
    Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medications for COPD: a review of effectiveness.
    Grimes GC; Manning JL; Patel P; Via RM
    Am Fam Physician; 2007 Oct; 76(8):1141-8. PubMed ID: 17990836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diagnosis and management of chronic obstructive pulmonary disease].
    Sato N; Kanazawa M
    Kyobu Geka; 2007 Aug; 60(9):841-8. PubMed ID: 17703625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Medication use patterns associated with spirometry in diagnosing COPD.
    Joo MJ; Lee TA; Au DH; Fitzgibbon ML; Weiss KB
    COPD; 2008 Dec; 5(6):360-8. PubMed ID: 19353350
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The new COPD guidelines reviewed. Smoking cessation--and what else?].
    Wepner U
    MMW Fortschr Med; 2003 Feb; 145(8):6-8. PubMed ID: 12661433
    [No Abstract]   [Full Text] [Related]  

  • 56. Preventing chronic obstructive pulmonary disease: what is known and what needs to be done to make a difference to the patient?
    Wise RA; Tashkin DP
    Am J Med; 2007 Aug; 120(8 Suppl 1):S14-22. PubMed ID: 17678939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [COPD in the year 2005].
    John M; Witt C
    MMW Fortschr Med; 2005 Mar; 147(11):41-3. PubMed ID: 15803849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Not Available].
    Barandun J
    Praxis (Bern 1994); 2017 Apr; 106(9):465-469. PubMed ID: 28443715
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD.
    Calverley PM; Eriksson G; Jenkins CR; Anzueto AR; Make BJ; Persson A; Fagerås M; Postma DS
    Int J Chron Obstruct Pulmon Dis; 2017; 12():13-25. PubMed ID: 28031707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.